Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 5:35 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2161–2184 of 17,766 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Population Clear all

Conditions: HIV Prevention
Interventions: STARS: Sistas Talking About Real Solutions, General Health & Nutrition; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 29 Years · Female only
Enrollment: 855 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2006
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Episodic Migraine
Interventions: Botulinum toxin type A, Placebo; Biological · Other
Lead sponsor: Ipsen; Industry
Eligibility: 18 Years and older
Enrollment: 751 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 66
States / cities: Birmingham, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 58 more

Conditions: PTSD
Interventions: Cognitive Processing Therapy; Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 900 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Acute Lung Injury (ALI) Associated With COVID-19, Lung Inflammation Associated With COVID-19
Interventions: TD-0903, Placebo; Drug
Lead sponsor: Theravance Biopharma; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 235 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 12
States / cities: Duarte, California • Denver, Colorado • Sebring, Florida + 9 more

Conditions: Herpes Zoster
Interventions: Herpes Zoster vaccine GSK 1437173A, GSK Biologicals' quadrivalent seasonal influenza vaccine FLU-D-QIV GSK2321138A; Biological
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 50 Years and older
Enrollment: 829 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 3
States / cities: Phoenix, Arizona • Carnegie, Pennsylvania • Erie, Pennsylvania

Conditions: Palliative Care
Interventions: Intervention (Promotora); Behavioral
Lead sponsor: Texas Tech University Health Sciences Center, El Paso; Other
Eligibility: 18 Years to 100 Years
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: El Paso, Texas

Conditions: Anterior Cervical Discectomy and Fusion
Interventions: Augmented Reality Enhanced Preoperative Counseling, Standard preoperative counseling; Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 80 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Major Depressive Disorder (MDD)
Interventions: GeneSight Psychotropic; Genetic
Lead sponsor: Assurex Health Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 1,398 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 61
States / cities: Birmingham, Alabama • Bellflower, California • Chino, California + 52 more

Conditions: Breast Cancer, Prehabilitation, Physical Activity, Surgery
Interventions: Exercise, Prehabilitation Education; Behavioral
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Rett Syndrome, Family Caregivers, Social Support, Psychological Support
Interventions: Those who have patients prescribed Daybue, Caregiver Speaks + Daybue; Other
Lead sponsor: Colorado State University; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Fort Collins, Colorado

Conditions: Biliary Atresia
Interventions: Filgrastim; Drug
Lead sponsor: Holterman, Ai-Xuan, M.D.; Individual
Eligibility: 14 Days to 180 Days
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Autism Spectrum Disorder
Interventions: Placebo, RG7314; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years to 45 Years · Male only
Enrollment: 223 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 56
States / cities: Phoenix, Arizona • Sacramento, California • San Diego, California + 26 more

Conditions: Antisocial Behavior
Interventions: Attention to Context (ATC) training, Affective Cognitive Control (ACC) training; Behavioral
Lead sponsor: The Mind Research Network; Other
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 288 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Healthy
Interventions: placebo, lixivaptan, moxifloxacin; Drug
Lead sponsor: CardioKine Inc.; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 298 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Diabetes, Autoimmune
Interventions: DiaPep277; Drug
Lead sponsor: DeveloGen Israel, Ltd.; Industry
Eligibility: 30 Years to 65 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2007
U.S. locations: 7
States / cities: Birmingham, Alabama • Aurora, Colorado • Lexington, Kentucky + 4 more

Conditions: Hiv, Sexually Transmitted Diseases, Aging
Interventions: safe sex and HIV/STD prevention education via a website, written materials on safe sex; Behavioral · Other
Lead sponsor: Environment and Health Group, Inc.; Industry
Eligibility: 50 Years to 70 Years · Female only
Enrollment: 331 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2018
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Non-cystic Fibrosis Bronchiectasis
Interventions: Benralizumab, Placebo to Benralizumab; Biological
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 130 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 4
States / cities: Birmingham, Alabama • Newport Beach, California • Northridge, California + 1 more

Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: GSK5784283, Placebo, Standard of care; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 40 Years to 80 Years
Enrollment: 624 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 5
States / cities: Doral, Florida • Lake Charles, Louisiana • Humble, Texas + 2 more

Conditions: Colorectal Cancer, Fatigue
Interventions: Walk With Ease; Behavioral
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 60 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Pain, Anxiety
Interventions: Synera; Drug
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years and older · Female only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Manhasset, New York

Conditions: Diabetic Neuropathies
Interventions: pregabalin; Drug
Lead sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 53
States / cities: Tuscaloosa, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 44 more

Conditions: Communication, Multidisciplinary
Interventions: Interventional Survey; Behavioral
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 21 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Postoperative Pain, Shoulder Pain
Interventions: Cold Compression (CC), Ice Wrap (IW); Device · Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 75 Years
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Boulder, Colorado

Conditions: Chronic Rhinosinusitis (Diagnosis)
Interventions: Lactobacillus sakei proBio65, Isotonic Saline Solution; Drug · Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Search by objective public record fields.

S.T.A.R.S.: Sistas Talking About Real Solutions

A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults

PTSD Treatment for Incarcerated Men and Women: AV

TD-0903 for ALI Associated With COVID-19

Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older

With Love: Using Promotoras for a Hispanic Community Palliative Care Promotora Palliative Care

The Effect of AR in Patient Pre-operative Education

Genomics Used to Improve DEpression Decisions

IMpact of PRehabilitation in Oncology Via Exercise - Breast Cancer

Adapting a Psychosocial Support Intervention for the Rett Syndrome Community

Part II: Granulocyte-Colony Stimulating Factor Adjunct Therapy for Biliary Atresia

A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)

Matching Treatments to Cognitive Deficits in Offenders With Substance Use Disorders

A Study to Define the ECG Effects of Lixivaptan Compared to Placebo and Moxifloxacin in Healthy Adult Men and Women: A Thorough ECG Study

Safety, Tolerability, Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in Latent Autoimmune Diabetes in Adults (LADA)

Prevention of HIV/AIDS and STDs in Women Over Fifty

Efficacy and Safety of Benralizumab in Patients With Non-cystic Fibrosis Bronchiectasis

A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)

Physical Activity Intervention for Older Patients During Chemotherapy for Colorectal Cancer

Study of Use of Synera for Pain During Local Skin Infiltration With Lidocaine Before Epidural Placement

Pregabalin vs Placebo in Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

Values and Options in Cancer Care 2 (VOICE 2) A Randomized Pilot Study

Compression and Cold Therapy on the Post-Operative Shoulder

Topical Probiotic Sinus Irrigations for Treating Chronic Sinusitis